|
|
|
Volumn 26, Issue 1 SUPPL. 4, 1999, Pages 3-11
|
|
Chemotherapy for non-small cell lung cancer: Have we reached a New Plateau?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
EPIRUBICIN;
GEMCITABINE;
IFOSFAMIDE;
MITOMYCIN C;
NAVELBINE;
PACLITAXEL;
TENIPOSIDE;
TIRAPAZAMINE;
VINDESINE;
BONE MARROW SUPPRESSION;
CLINICAL TRIAL;
DRUG EFFICACY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LUNG NON SMALL CELL CANCER;
NAUSEA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
SURVIVAL RATE;
VOMITING;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
CARCINOMA, NON-SMALL-CELL LUNG;
DEOXYCYTIDINE;
ENZYME INHIBITORS;
HUMANS;
LUNG NEOPLASMS;
PACLITAXEL;
PALLIATIVE CARE;
RANDOMIZED CONTROLLED TRIALS;
TRIAZINES;
VINBLASTINE;
|
|
EID: 0032919619
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (80)
|
|
References (33)
|
